Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments
Beyond Air has agreed to sell its 58% stake in NeuroNOS Israel to UNIVO Pharmaceutical Industries, receiving a 19.99% equity stake in UNIVO and warrants upon closing. The deal includes up to $32.5 million in potential milestone payments for Beyond Air, split between $6.5 million for development milestones and $26 million tied to commercial sales thresholds.
Key figures
- Warrant term years
- 5
- Univo warrants percent
- 19.99%
- Commercial milestones usd
- $26.0 million
- Development milestones usd
- $6.5 million
- Warrant exercise price usd
- $0.01
- Neuro NOS stake sold percent
- 58%
- Univo equity received percent
- 19.99%
- Potential milestone payments usd
- $32.5 million
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.